Randomized controlled trial of an energy conservation course for persons with multiple sclerosis

被引:149
|
作者
Mathiowetz, VG
Finlayson, ML
Matuska, KM
Chen, HY
Luo, P
机构
[1] Univ Minnesota, Program Occupat Therapy, Minneapolis, MN 55455 USA
[2] Univ Illinois, Dept Occupat Therapy MC 811, Chicago, IL 60612 USA
[3] Coll St Catherine, Dept Occupat Therapy, St Paul, MN 55415 USA
[4] Univ Illinois, Dept Epidemiol & Biostat, Chicago, IL 60612 USA
[5] Edward Hines Jr Vet Adm Hosp, CSPCC, Hines, IL 60141 USA
关键词
energy effectiveness; fatigue; occupational therapy; outcomes; quality of life; rehabilitation; self-efficacy; work simplification;
D O I
10.1191/1352458505ms1198oa
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the short-term efficacy and effectiveness of a six-week energy conservation course on fatigue impact, quality of life and self-efficacy for persons with multiple sclerosis ( MS). Methods: In this randomized controlled trial, we randomly assigned 169 persons with MS to an immediate intervention group or a delayed control group using a crossover design. The outcome measures: Fatigue Impact Scale, SF-36 Health Survey and Self-Efficacy for Performing Energy Conservation Strategies were measured before and after courses and no intervention control periods. We performed intent-to-treat analysis and compliers-only analyses using mixed effects analysis of variance models. Results: Taking the energy conservation course had significant effects on reducing the physical and social subscales of Fatigue Impact Scale and on increasing the Vitality subscale of the SF-36 scores compared with not taking the course. Additional subscales were significant depending on methods of analyses. Self-Efficacy for Performing Energy Conservation Strategies Assessment increased significantly ( P < 0.05) postcourse compared to precourse. Conclusions: Results support the efficacy and effectiveness of the energy conservation course to decrease fatigue impact, and to increase self-efficacy and some aspects of quality of life.
引用
收藏
页码:592 / 601
页数:10
相关论文
共 50 条
  • [31] Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial
    Defer, Gilles
    Fedrizzi, Sophie
    Chevanne, Damien
    Montastruc, Francois
    Briant, Anais R.
    Parienti, Jean-Jacques
    Peyro-Saint-Paul, Laure
    DRUG SAFETY, 2021, 44 (02) : 223 - 233
  • [32] Experimental protocol of a randomized controlled clinical trial investigating exercise, subclinical atherosclerosis, and walking mobility in persons with multiple sclerosis
    Griffith, Garett
    Klaren, Rachel E.
    Motl, Robert W.
    Baynard, Tracy
    Fernhall, Bo
    CONTEMPORARY CLINICAL TRIALS, 2015, 41 : 280 - 286
  • [33] IMPACT OF AEROBIC EXERCISE ON CLINICAL AND MAGNETIC RESONANCE IMAGING BIOMARKERS IN PERSONS WITH MULTIPLE SCLEROSIS: AN EXPLORATORY RANDOMIZED CONTROLLED TRIAL
    Savsek, Lina
    Stergar, Tamara
    Strojnik, Vojko
    Ihan, Alojz
    Koren, Ales
    Spiclin, Ziga
    Jazbec, Sasa Sega
    JOURNAL OF REHABILITATION MEDICINE, 2021, 53 (04)
  • [34] High Intensity Aerobic and Resistance Exercise Can Improve Glucose Tolerance in Persons With Multiple Sclerosis A Randomized Controlled Trial
    Wens, Inez
    Dalgas, Ulrik
    Vandenabeele, Frank
    Verboven, Kenneth
    Hansen, Dominique
    Deckx, Nathalie
    Cools, Nathalie
    Eijnde, Bert O.
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2017, 96 (03) : 161 - 166
  • [35] Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial
    Gilles Defer
    Sophie Fedrizzi
    Damien Chevanne
    François Montastruc
    Anais R. Briant
    Jean-Jacques Parienti
    Laure Peyro-Saint-Paul
    Drug Safety, 2021, 44 : 223 - 233
  • [36] Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis
    Panitch, HS
    Thisted, RA
    Smith, RA
    Wynn, DR
    Wymer, JP
    Achiron, A
    Vollmer, TL
    Mandler, RN
    Dietrich, DW
    Fletcher, M
    Pope, LE
    Berg, JE
    Miller, A
    ANNALS OF NEUROLOGY, 2006, 59 (05) : 780 - 787
  • [37] A Randomized Controlled Trial of Neuroprotection with Lamotrigine in Secondary Progressive Multiple Sclerosis
    Kapoor, Raju
    Furby, Julian
    Hayton, Thomas
    Smith, Kenneth
    Altmann, Daniel
    Brenner, Robert
    Chataway, Jeremy
    Hughes, Richard
    Miller, David
    NEUROLOGY, 2010, 74 (09) : A193 - A193
  • [38] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    Polman, CH
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Toal, M
    Lynn, F
    Panzara, MA
    Sandrock, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 899 - 910
  • [39] Online meditation training for people with multiple sclerosis: A randomized controlled trial
    Cavalera, Cesare
    Rovaris, Marco
    Mendozzi, Laura
    Pugnetti, Luigi
    Garegnani, Massimo
    Castelnuovo, Gianluca
    Molinari, Enrico
    Pagnini, Francesco
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (04) : 610 - 617
  • [40] Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis
    Brian M. Sandroff
    Rachel E. Klaren
    Lara A. Pilutti
    Deirdre Dlugonski
    Ralph H. B. Benedict
    Robert W. Motl
    Journal of Neurology, 2014, 261 : 363 - 372